+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Vasomotor Symptoms Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Vasomotor Symptoms Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Vasomotor Symptoms of Menopause - Pipeline Insight, 2024 - Product Thumbnail Image

Vasomotor Symptoms of Menopause - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
LAMEA Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

LAMEA Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Middle East, Africa
From
Asia Pacific Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Asia Pacific Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Asia Pacific
From
Europe Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Europe
From
North America Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

North America Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 69 Pages
  • North America
From
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 64 Pages
  • Global
From
Esophageal Cancer Global Market Report 2024 - Product Thumbnail Image

Esophageal Cancer Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Diabetic Neuropathy Drugs Market 2021-2025 - Product Thumbnail Image

Diabetic Neuropathy Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Rheumatoid Arthritis Drugs Global Market Report 2024 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Hyperphosphatemia Treatment Global Market Report 2024 - Product Thumbnail Image

Hyperphosphatemia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 734 Pages
  • Global
From
Needle-Free Devices: Technologies and Global Markets - Product Thumbnail Image

Needle-Free Devices: Technologies and Global Markets

  • Report
  • March 2019
  • 170 Pages
  • Global
From
Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways - Product Thumbnail Image

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways

  • Report
  • August 2019
  • 488 Pages
  • Global
From
Chromoblastomycosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Chromoblastomycosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 101 Pages
  • Global
From
Monoclonal Antibodies (MAs) Global Market Report 2024 - Product Thumbnail Image

Monoclonal Antibodies (MAs) Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Arthritis Monoclonal Antibodies Global Market Report 2024 - Product Thumbnail Image

Arthritis Monoclonal Antibodies Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class; Action Mechanism, and Geography - Product Thumbnail Image

Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class; Action Mechanism, and Geography

  • Report
  • April 2021
  • Global
From
Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 847 Pages
  • Global
From
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 322 Pages
  • Global
From
Loading Indicator